{
    "Case ID": "058045",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [],
    "Legal_Issue": [
        "Can Nycomed amend its counterclaim to allege contributory infringement by Apotex and Novopharm?"
    ],
    "Governing_Law": [],
    "Procedural_Stage": [
        "Appeal"
    ],
    "Evidence_Assessment": [],
    "Decision_Outcome": [
        "Nycomed's appeals dismissed"
    ],
    "Burden_of_Proof": [],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "The General Rule states that selling an article not infringing itself does not constitute patent infringement unless it falls under two exceptions: (a) selling all components of the invention for assembly, or (b) knowingly inducing procurement of infringement. The court applies the stringent three-prong Inducement Test for contributory infringement."
    ],
    "Standard_of_Review": [
        "de novo review"
    ],
    "Procedural_Issue": [
        "Denial of amendment to counterclaim"
    ],
    "Grounds_for_Claim": [
        "Allegation of contributory infringement by Apotex and Novopharm"
    ],
    "Outcome_on_Merits": [
        "Contributory inducement is not a reasonable cause of action; claim rejected"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Appeals dismissed"
    ],
    "Review_Standard": [
        "de novo"
    ],
    "Procedural_Fairness_Assessment": [],
    "Key_Evidence_Considered": [],
    "Legal_Framework": [
        "Canadian patent law"
    ],
    "Applicant_Challenge": [
        "Nycomed sought to amend its counterclaim"
    ],
    "Court_Result": [
        "Amendment denied; appeals dismissed"
    ],
    "Legal_Rule_Source": [
        "Relevant case law"
    ],
    "Standard_of_Proof": [],
    "Defendant_Response": [
        "Apotex and Novopharm opposed the amendment"
    ],
    "Evidence_Type": [],
    "Remedy_Requested": [
        "Amendment of counterclaim to include contributory infringement"
    ],
    "Outcome": [
        "Amendment not allowed; costs awarded to Apotex and Novopharm"
    ],
    "Decision_Authority": [
        "Federal Court"
    ],
    "Remedy_Sought": [
        "Recognition of contributory infringement claim"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on appeal"
    ],
    "Legal_Provision": [],
    "Authority": [
        "Prothonotary Milczynski (initial decision), Federal Court (appellate review)"
    ],
    "Claimant_Status": [
        "Nycomed as counterclaimant"
    ],
    "Legal_Provision_Cited": [],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Failure to meet the three-prong Inducement Test; lack of legal basis for contributory inducement claim"
    ],
    "Applicable_Process": [
        "Amendment of pleadings in federal litigation"
    ],
    "Outcome_of_Review": [
        "Affirmed denial of amendment"
    ],
    "Pending_Relief_or_Application": [
        "Application to amend counterclaim"
    ],
    "Jurisdiction": [
        "Federal Court"
    ],
    "Governing_Rule": [
        "The General Rule on contributory patent infringement and the Inducement Test"
    ]
}